Chemotherapy-induced oral food intake impairment;Difficultés alimentaires liées à la chimiothérapie

Oncologie

Volumn 11, Issue 4, 2009, Pages 204-210

  Di Fiore, F ^a   Rigal, O ^a  

^a NONE

Author keywords

Chemotherapyinduced side effects; Oral food intake impairment

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; BORTEZOMIB; CARBOPLATIN; CARMUSTINE; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IDARUBICIN; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; MITOMYCIN; MITOXANTRONE; OXALIPLATIN; PACLITAXEL; PEMETREXED; STREPTOZOCIN; TOPOTECAN; UNINDEXED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CANCER THERAPY; DAILY LIFE ACTIVITY; EVIDENCE BASED PRACTICE; FOOD INTAKE; HUMAN; MUCOSA INFLAMMATION; NAUSEA; NUTRITIONAL DISORDER; OLFACTORY NERVE DISEASE; QUALITY OF LIFE; RISK FACTOR; SENSORY DYSFUNCTION; SOCIAL PSYCHOLOGY; TASTE DISORDER; VOMITING;

EID: 65649134359     PISSN: 12923818     EISSN: 17652839     Source Type: Journal    
DOI: 10.1007/s10269-009-1051-3     Document Type: Article

References (37)

1. W. Bensinger M. Shubert K. Ang 2008 NCCN Task force report: prevention and management of mucositis in cancer care JNCCN 6 Suppl1 S1 S21
2. B.M. Bernhardson C. Tishelman L.E. Rutqvist 2007 Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study J Pain Symptom Manage 34 403 412 (Pubitemid 47454700)
3. B.M. Bernhardson C. Tishelman L.E. Rutqvist 2008 Self-reported taste and smell changes during cancer chemotherapy Support Care Cancer 16 275 283
4. I.L. Bernstein 1978 Learned taste aversions in children receiving chemotherapy Science 200 1302 1303 (Pubitemid 8405765)
5. M.V. Berteretche A.M. Dalix A.M. d'Ornano 2004 Decreased taste sensitivity in cancer patients under chemotherapy Support Care Cancer 12 571 576 (Pubitemid 39062548)
6. N. Blijlevens M. Schwenkglenks P. Bacon 2008 Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy: European Blood and Marrow Transplantation Mucositis Advisory Group J Clin Oncol 26 1519 1525
7. B. Bloechl-Daum R. Deuson P. Mavros 2006 Delayed nausea and vomiting continue to reduce patient's quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment J Clin Oncol 24 4472 4478 (Pubitemid 46630986)
8. T.D. Brisbois J.L. Hutton V.E. Baracos W.V. Wismer 2006 Taste and smell abnormalities as an independent cause of failure of food intake in patients with advanced cancer-an argument for the application of sensory science J Palliat Care 22 111 114
9. Cancer Care Ontario Practice Guidelines Initiative: use of 5-HT3 antagonists in patients receiving moderately or highly emetogenic chemotherapy (2000) Practice guideline report 12-3, 1/2003 update. http//www.cancercare.on. ca/pdf/pebc12-3f.pdf
10. T.B. Comeau J.B. Epstein C. Migas 2001 Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge Support Care Cancer 9 575 580 (Pubitemid 33063717)
11. R.W. D'Acquisto L.B. Tyson R.J. Gralla 1987 The influence of chronic high alcohol intake on chemotherapy-induced nausea and vomiting Proc Am Soc Clin Oncol 5 257
12. M. De Boer-Dennert R. de Wit P. Schmitz 1997 Patients perceptions of the side effects of chemotherapy: the influence of 5-HT3 antagonists Br J Cancer 76 1055 10561 (Pubitemid 27434663)
13. R. De Wit J. Herrstedt B. Rapoport 2003 Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy J Clin Oncol 21 4105 4111 (Pubitemid 46606177)
14. M. Duncan G. Grant 2003 Review article: oral and intestinal mucositis: causes and possible treatments Aliment Pharmacol Ther 18 853 874 (Pubitemid 37346671)
15. Enquêtes sur les difficultés alimentaires liées à une chimiothérapie (2006) Rapport final juin Institut national du cancer. http://www.e-cancer.fr/v1/fichiers/public/enquete-difficultees- alimentaires-chimiotherapie-050906.pdf
16. O. Greling H. Eicher 2005 Should 5-HT3 receptor antagonists be administered beyond 24 hours following chemotherapy to prevent delayed emesis? Systematic reevaluation of clinical evidence and drug cost implications J Clin Oncol 23 1289 1294 (Pubitemid 46202287)
17. P.J. Hesketh 2008 Chemotherapy-induced nausea and vomiting N Engl J Med 358 2482 2494
18. P.J. Hesketh S.M. Grunberg R.J. Gralla 2003 The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomised, double blind, placebo-controlled trial in patients receiving high-dose cisplatin: the Aprepitant Protocol 052 Study Group J Clin Oncol 21 4112 4119 (Pubitemid 46606178)
19. P.J. Hesketh M.G. Kris S.M. Grunberg 1997 Proposal for classifying the acute emetogenicity of cancer chemotherapy J Clin Oncol 15 103 109 (Pubitemid 27020563)
20. J.L. Hutton V.E. Baracos W.V. Wismer 2007 Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer J Pain Symptom Manage 33 156 165 (Pubitemid 46186864)
21. Jakubowicz C (2005) Troubles du goût et de l'alimentation chez les malades du cancer traités par chimiothérapie. Institut national du cancer https://www.e-cancer.fr/v1/fichiers/public/troubles-gout-alimentation- schum.doc
22. Jakubowicz C (2006) Chemotherapy and the pleasure of eating. The point of view of the human sciences. Oncology 170-174
23. K. Jordan C. Kasper H.J. Schmoll 2005 Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment Eur J Cancer 41 199 205 (Pubitemid 40126951)
24. D. Keefe M. Shubert L. Elting 2007 Updated clinical practice guidelines for the prevention and treatment of mucositis Cancer 109 820 831 (Pubitemid 46335677)
25. A. Kettaneh O. Fain J. Stirnemann M. Thomas 2002 Taste disorders Rev Med Int 23 622 631
26. M.G. Kris P.J. Hesketh M.R. Somerfield 2006 American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006 J Clin Oncol 24 2932 2947 (Pubitemid 46630595)
27. M. Lipkin 1965 Cell replication in the gastro-intestinal tract of man Gastroenterology 48 616 662
28. M. Lipkin P. Sherlock B. Bell 1965 Cell proliferation kinetics in the gastro-intestinal tract of man. II Cell renewal in the stomach ileum, colon, rectum Gastroenterology 45 721 772
29. E. Mitchell 2006 Gastro-intestinal toxicity of chemotherapeutic agents Semin Oncol 33 106 120
30. A. Naeim S. Dry K. Lorenz 2008 Evidence-based recommendations for cancer nausea and vomiting J Clin Oncol 26 3903 3910
31. J. Raber-Durlacher N. Weijl M. Abus Saris 2000 Oral mucositis in patients treated with chemotherapy for solids tumors: a retrospective analysis of 150 cases Support Care Cancer 8 366 371 (Pubitemid 30650520)
32. L. Rosen E. Abdi I. Davis 2006 Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy J Clin Oncol 24 5194 5200 (Pubitemid 46631362)
33. M.D. Schwartz P.B. Jacobsen D.H. Bovbjerg 1996 Role of nausea in the development of aversions to a beverage paired with chemotherapy treatment in cancer patients Physiol Behav 59 659 663 (Pubitemid 26110681)
34. S. Sonis 1998 Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity Oral Oncol 34 39 43 (Pubitemid 28210529)
35. S. Sonis G. Oster H. Fucks 2001 Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation J Clin Oncol 19 2201 2205 (Pubitemid 32372323)
36. F. Strasser R. Demmer C. Böhme 2008 Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double blind study Oncologist 13 337 346
37. R. Wickham M. Rehwaldt C. Kefer 1999 Taste changes experienced by patients receiving chemotherapy Oncol Nurs Forum 26 697 706